Search results
- 3.8900Add to watchlist-0.1800 (-4.42%)At close:4:00 PM EDTWed. May 29, 20243.9000 +0.01 (+0.26%)After hrs:5:50 PM EDTWed. May 29, 2024Nasdaq Real Time Price (USD) · Market closed
- Open4.0200High4.0200Low3.8900
- Mkt Cap329.26MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close4.070052 Wk. Low3.250052 Wk. High10.4500
Related stocks
5 days ago · 1.27. +0.30% Markets. Data. Anavex Life Sciences Corp. AVXL:US. Nasdaq GS (USD) · Market closed. 4.00. –0.17 –4.08% As of 12:00 AM EDT 05/24/24. Prev. close. 4.17 USD. 4.00 USD. 3:58 PM. 9:30a...
- 40
5 days ago · 18 days ago - Accesswire. Get a real-time Anavex Life Sciences Corp. (AVXL) stock price quote with breaking news, financials, statistics, charts and more.
- 3.655-3.800
- 3.800
- 3.760
- 559,056
People also ask
What is the price of avxl stock?
How many shares does avxl hold?
What happened to ANAVEX Life Sciences Corp (avxl) stock?
Is avxl stock in a downtrend?
5 days ago · Their AVXL share price targets range from $40.00 to $40.00. On average, they predict the company's share price to reach $40.00 in the next twelve months. This suggests a possible upside of 900.0% from the stock's current price. View analysts price targets for AVXL or view top-rated stocks among Wall Street analysts.
- (844) 689-3939
- 51 W 52ND STREET 7TH FLOOR, NEW YORK NY, 10019
- ir@anavex.com
5 days ago · A high-level overview of Anavex Life Sciences Corp. (AVXL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
2 days ago · Detailed Quote for Monday, May 27, 2024 06:09 PM; Company Name: Anavex Life Sciences Corp. Dow Jones Industry: Biotechnology: Exchange: NAS: Shares Outstanding: 82,112,510: Market Cap: 338.57M:...
5 days ago · AVXL's stock price has decreased by -56.08% in the past year and price targets may not have had time to catch up. Stock Price Forecast The 1 analyst with a 12-month price forecast for AVXL stock has a target of 40, which predicts an increase of 900.00% from the current stock price of 4.00.
2 days ago · 1Y. -57.1% Updated. 27 May, 2024. Data. Company Financials +. 2 Analysts. AVXL Stock Overview. A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. About the company. Rewards. Risk Analysis. Makes less than USD$1m in revenue ($0)